Literature DB >> 16998622

Compound overload of copper and iron in patients with Wilson's disease.

Hisao Hayashi1, Motoyoshi Yano, Yoshikazu Fujita, Shinya Wakusawa.   

Abstract

This review of the copper-iron interaction in Wilson's disease was mainly based on ten patients (three females and seven males) studied in our institutes because the genetic tests of ATP7B for Wilson's disease of primary copper toxicosis and HFE for hemochromatosis, the biochemical parameters of copper and iron, and morphological studies on biopsied liver specimens were complete. All patients had hypoceruloplasminemia and hepatic lesions compatible with Wilson's disease. One patient was homozygous and nine patients were compound heterozygous for the mutations in ATP7B, and all patients were free from the major mutation, C282Y, of HFE. The biochemical parameters of iron metabolism were not specific, except for serum ferritin concentration. Judging from the traditional criteria, seven patients had hyperferritinemia. Histochemical iron was stained in the livers of seven patients and histochemical copper was found in nine patients. Microanalysis was more sensitive than histochemistry, detecting copper and iron accumulation in the hepatocellular lipofuscin particles of all patients. Using an improved fixative, intralipofuscin distribution was found to be different between cuprothionein and iron complexes. Iron overload in Wilson's disease might be worsened after treatment because of the close relation to hypoceruloplasminemia, in which the iron efflux from the liver to the circulation is disturbed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998622     DOI: 10.1007/s00795-006-0326-7

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  34 in total

1.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Two male patients with Wilson's disease treated using trientine and iron reduction therapy.

Authors:  Hisao Hayashi; Toshio Ueno; Motoyoshi Yano; Toshihide Okada; Hiroshi Mabuchi
Journal:  J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 4.029

4.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.

Authors:  K Yoshida; K Furihata; S Takeda; A Nakamura; K Yamamoto; H Morita; S Hiyamuta; S Ikeda; N Shimizu; N Yanagisawa
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

5.  Effect of treatment of Wilson's disease on natural history of haemochromatosis.

Authors:  J M Walshe; D W Cox
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

6.  Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C.

Authors:  A Piperno; M Sampietro; R D'Alba; L Roffi; S Fargion; S Parma; C Nicoli; N Corbetta; M Pozzi; V Arosio; G Boari; G Fiorelli
Journal:  Liver       Date:  1996-08

7.  HFE gene mutations and iron metabolism in Wilson's disease.

Authors:  Andreas Erhardt; Arne Hoffmann; Harald Hefter; Dieter Häussinger
Journal:  Liver       Date:  2002-12

8.  Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.

Authors:  Y Yamaguchi; M E Heiny; J D Gitlin
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

9.  Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration.

Authors:  H Miyajima; Y Nishimura; K Mizoguchi; M Sakamoto; T Shimizu; N Honda
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

10.  Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease.

Authors:  Yasuaki Suzuki; Hiroyuki Saito; Masako Suzuki; Yayoi Hosoki; Shinobu Sakurai; Yoshinori Fujimoto; Yutaka Kohgo
Journal:  Alcohol Clin Exp Res       Date:  2002-08       Impact factor: 3.455

View more
  13 in total

Review 1.  Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Authors:  Sabine Weiskirchen; Philipp Kim; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2019-04

2.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

3.  Brief exposure to copper activates lysosomal exocytosis.

Authors:  Karina Peña; Jessica Coblenz; Kirill Kiselyov
Journal:  Cell Calcium       Date:  2015-01-12       Impact factor: 6.817

4.  Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.

Authors:  Elizabeth C Lee; Emmeline Ha; Sanghamitra Singh; Linda Legesse; Sana Ahmad; Elena Karnaukhova; Robert P Donaldson; Aleksandar M Jeremic
Journal:  Phys Chem Chem Phys       Date:  2013-08-14       Impact factor: 3.676

5.  Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis.

Authors:  Hisao Hayashi; Ai Hattori; Yasuaki Tatsumi; Kazuhiko Hayashi; Yoshiaki Katano; Jun Ueyama; Shinya Wakusawa; Motoyoshi Yano; Hidemi Goto
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

Review 6.  Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.

Authors:  Hiroko Kodama; Chie Fujisawa; Wattanaporn Bhadhprasit
Journal:  Curr Drug Metab       Date:  2012-03       Impact factor: 3.731

7.  Copper chelation and interleukin-6 proinflammatory cytokine effects on expression of different proteins involved in iron metabolism in HepG2 cell line.

Authors:  Luca Marco Di Bella; Roberto Alampi; Flavia Biundo; Giovanni Toscano; Maria Rosa Felice
Journal:  BMC Biochem       Date:  2017-01-24       Impact factor: 4.059

8.  Transition metals activate TFEB in overexpressing cells.

Authors:  Karina A Peña; Kirill Kiselyov
Journal:  Biochem J       Date:  2015-06-11       Impact factor: 3.857

9.  MR image mimicking the "eye of the tiger" sign in Wilson's disease.

Authors:  T Litwin; M Karlinski; M Skowrońska; K Dziezyc; M Gołębiowski; A Członkowska
Journal:  J Neurol       Date:  2014-03-26       Impact factor: 4.849

10.  Antioxidation of Cerium Oxide Nanoparticles to Several Series of Oxidative Damage Related to Type II Diabetes Mellitus In Vitro.

Authors:  Jing-Hui Zhai; Yi Wu; Xiao-Ying Wang; Yue Cao; Kan Xu; Li Xu; Yi Guo
Journal:  Med Sci Monit       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.